Diagnostic Value of CA 19-9 and Carcinoembryonic Antigen for Pancreatic Cancer: A Meta-Analysis
Gastroenterology Research and Practice, 2018 Background. CA 19-9 and carcinoembryonic antigen (CEA) are widely used for the diagnosis of pancreatic cancer. The purpose of the present study was to compare the diagnostic value of CA 19-9 with CEA for pancreatic cancer. Methods. The studies were obtained from electronic searches conducted in PubMed, Embase, and Cochrane Library databases until ...
Haibo Xing +6 more
openaire +4 more sources
Intralobar Pulmonary Sequestration and Increased Serum CA 19-9 [PDF]
European Journal of Case Reports in Internal Medicine, 2017 Intralobar pulmonary sequestration is an uncommon congenital lung anomaly which consists of a mass of normal lung tissue not connected to the normal tracheobronchial tree and supplied by an anomalous systemic artery.
Massimo Montalto +4 more
doaj +4 more sources
مجلة بغداد للعلومColorectal cancer (CRC) is a disease that begins exclusively in the colon or rectum and is caused by an abnormal proliferation of glandular epithelial cells in the colon. Carbohydrate antigen 19-9 (CA19-9), carcinoembryonic antigen (CEA), calcium (Ca),
Fenik Ahmed Nadir, Zeyan Abdullah Ali
doaj +3 more sources
Comparison of CA 72-4, CA 19-9 and CEA in the diagnosis and monitoring of gastric cancer
The International Journal of Biological Markers, 1995 In order to assess the utility of the tumor-associated antigen CA 72-4 in the diagnosis and monitoring of gastric cancer, this tumor marker was measured preoperatively in 718 patients.
F. Safi, V. Kuhns, H.G. Beger
doaj +2 more sources
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma. [PDF]
PLoS ONE, 2017 OBJECTIVES:Among patients who underwent primary surgery for non-small cell lung cancer (NSCLC), recurrent disease is frequent and cannot be accurately predicted solely from TNM stage and histopathological features.
Sofi Isaksson +7 more
doaj +2 more sources
Gastric Cancer with a Very High Serum CA 19-9 Level
Case Reports in Gastroenterology, 2011 Carbohydrate antigen 19-9 (CA 19-9) is a sensitive marker for pancreatic and hepatobiliary malignancies. The highest frequency of elevated serum CA 19-9 levels is found among patients with pancreatic cancer. CA 19-9 has recently been demonstrated to be a
Kazuya Kato +8 more
doaj +2 more sources
Reference Limits for Chromogranin A, CYFRA 21-1, CA 125, CA 19-9 and Carcinoembryonic Antigen in Patients with Chronic Kidney Disease [PDF]
The International Journal of Biological Markers, 2017 Background Patients with chronic kidney disease (CKD) may have increased plasma concentrations of some tumor markers even when no cancer is present.
Gustav Mikkelsen +4 more
doaj +3 more sources
Assessing prognosis in metastatic pancreatic cancer by the serum tumor marker CA 19-9: Pretreatment levels or kinetics during chemotherapy? [PDF]
, 2007 Background: The carbohydrate antigen 19-9 (CA 19-9) is currently the most widely used serum tumor marker in pancreatic cancer (PC). CA 19-9 pretreatment levels as well as CA 19-9 kinetics during systemic chemotherapy can provide prognostic information ...
Holdenrieder, Stefan +5 more
core +1 more source
Tumor associated antigens in diagnosis of serous effusions [PDF]
, 1988 The use of tumour associated antigens in the diagnosis of serous effusions was studied in 76 patients with benign and 200 patients with malignant disease.
Permanetter, W. +4 more
core +1 more source
Prognostic role of carcinoembryonic antigen and carbohydrate antigen 19-9 in metastatic colorectal cancer : a BRAF-mutant subset with high CA 19-9 level and poor outcome [PDF]
, 2018 BACKGROUND: Mutation status of RAS and BRAF, as well as serum levels of carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9), are biomarkers used in clinical management of patients with gastrointestinal cancers.
Per Pfeiffer +40 more
core +1 more source